Randomized Clinical Trial in Bellow-the-knee Angioplasty. Treatment of One or More Than One Artery.
1 other identifier
interventional
80
1 country
1
Brief Summary
It is a randomized study that intend to enroll 80 bellow-the-knee angioplasty procedures in which 40 procedures to treat one artery (standart) or more than one artery in the same procedure. The aim of this study is to know if this strategy increase healing velocity and limb salvage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 17, 2016
CompletedFirst Posted
Study publicly available on registry
March 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedAugust 28, 2019
August 1, 2019
1.3 years
March 17, 2016
August 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time of wound healing
Time in days necessary to the complete healing of the wound
1 year
Limb Salvage
Time free of major amputation
1 year
Study Arms (2)
One Artery
EXPERIMENTALIn this arm after obtain the good result after the angioplasty of one artery the procedure stops
More than one artery
EXPERIMENTALIn this arm, after obtain a good result of the angioplasty of one artery, we continue trying one or two more arteries
Interventions
angioplasty of the arteries bellow-the-knee
Eligibility Criteria
You may qualify if:
- Occlusion of the three arteries bellow the knee previously
- Rutherford 5 - ischemic lesion of the foot
- Informative Term
- At least one patente vessel in pedal arch
You may not qualify if:
- allergy to aspirin, clopidogrel or contrast media
- renal impairment
- Tasc D lesion in femoral or popliteal arteries
- no undersatnting patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Santa Marcelina Hospital
São Paulo, 08270000, Brazil
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The moment of randomization was after the successful accomplish of the recanalizaripn of the first artery. The used 80 sealed papers - 40 for each treatment. The nurse pick up one of the mixed papers and the procedure stops or continuous to the another artery depending on the randomization.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
March 17, 2016
First Posted
March 22, 2016
Study Start
March 1, 2016
Primary Completion
June 1, 2017
Study Completion
July 1, 2017
Last Updated
August 28, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share